Sen. James M. Inhofe bought Bristol-Myers Squibb Company (BMY)
Sen. James M. Inhofe (R-OK) · $15K–$50K · traded Aug 8, 2016
- Transaction
- Bought
- Amount
- $15K–$50K
- Owner
- The member
- Traded
- Aug 8, 2016
- Disclosed
- Aug 9, 2016
- Days to disclose
- 1
- Asset type
- Stock
- As filed
- Bristol-Myers Squibb Company
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Aug 9, 2016$50K–$100K
Sold (full) Express Scripts Holding Company ESRX
$50K–$100K · Traded Aug 8, 2016 · disclosed Aug 9, 2016
- Aug 9, 2016$50K–$100K
$50K–$100K · Traded Aug 8, 2016 · disclosed Aug 9, 2016
Recent Congress trades in BMY
- Aug 5, 2026$1K–$15K
Sen. Tommy Tuberville (R-AL)
Sold Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Apr 15, 2025 · disclosed Aug 5, 2026 · filed 477 days later
Committee overlap: HELP - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 12, 2026$15K–$50K
Rep. Mike Kelly (R-PA-16)
Sold (full) Bristol-Myers Squibb Company BMY
$15K–$50K · Traded May 7, 2026 · disclosed Jun 12, 2026 · Spouse
- Feb 10, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
Sold Bristol-Myers Squibb Company BMY
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 10, 2026 · Spouse
- Jan 16, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
Sold (full) Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 16, 2026 · Joint
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Sold (full) Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Apr 28, 2025 · disclosed Jan 13, 2026 · filed 260 days later
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Oct 23, 2024 · disclosed Jan 13, 2026 · filed 447 days later
- Jan 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Dec 19, 2025 · disclosed Jan 12, 2026
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.